Clinicians' attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of life

Abstract

AimsLeft ventricular assist devices (LVADs) are implanted to support the circulation of patients with advanced heart failure. Patients approaching death, or their surrogates, may request withdrawal of LVAD support. We sought to study the attitudes and practices of heart failure clinicians regarding withdrawal of LVAD support in patients approaching death. Methods and resultsUsing internet-based and secure methods, we surveyed members of the European Society of Cardiology-Heart Failure Association (ESC-HFA), the International Society for Heart and Lung Transplantation (ISHLT), and the Heart Failure Society of America (HFSA) to assess their attitudes and practices regarding LVAD withdrawal for patients approaching death. The results indicated that clinicians have varied attitudes and practices regarding withdrawing LVAD support in these patients. Furthermore, ESC-HFA clinicians (primarily European) and ISHLT and HFSA clinicians (primarily North American) differed in their attitudes and practices regarding withdrawal of LVAD support, particularly its ethical and legal permissibility. For example, more European clinicians than North American clinicians regarded withdrawing LVAD support as a form of euthanasia. ConclusionOpinions and level of comfort with LVAD withdrawal vary among clinicians. Clinicians should be aware of suggested approaches or guidelines for managing requests for withdrawal of LVAD therapy.--

Investigating academic veterinarians’ knowledge of biostatistics: a web-based survey

“…However, our response rate of 4.38% is similar to that of web-based studies in previous research aimed at cardiologists (4%) (21), medical providers (4%) (20), primary care physicians (5.7%) (22), dental physicians (9.1%) (17) and a group of urologists (9.3%) (14). When similar studies are considered, our response rate is acceptable.…”

Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF

“…This suggests the need for further interventions to manage symptoms in patients with advanced CHF and further study of symptoms among other diseases. The growing number of studies on the use of palliative care among persons with ALS (Baxter et al, 2013; Maessen et al, 2009) and CHF (Kaasalainen et al, 2013; Lemond & Allen, 2011; Swetz et al, 2013) offer guidance on comprehensive approaches to symptom management. Further research is needed to examine the challenges in symptom management across transitions in care from the acute to long-term or home settings.…”

Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices

“…However, some physicians differentiate withdrawing LVAD support from withdrawing other life-sustaining therapies such as mechanical ventilation or vasopressor agents, suggesting a range of moral conflicts surrounding the dying patient on MCS. 35 While no physician may be compelled to perform an act or procedure to which he or she objects, consensus exists among the legal and ethical community that distinguishes killing from allowing to die. 32,33,36 The crucial difference lies in the primary intention: termination of a life, versus termination of a therapy that inhibits the occurrence of an otherwise natural death from lethal disease.…”